None

Avatrombopag/Avatrombopag is an important drug that belongs to the second generation oral thrombopoietin receptor agonist (TPO-RA). It is indicated primarily for the treatment of thrombocytopenia in adult patients with chronic liver disease scheduled to undergo surgery and in patients with chronic immune thrombocytopenia who have had an inadequate response to prior therapy. With the increasing clinical demand, avatrombopag has been widely used around the world. The drug was developed to improve patients' preoperative platelet counts, thereby reducing surgical risks and improving post-operative recovery.

About the manufacturer of avatrombopag, the original version of avatrombopag is produced and sold by Sweden'sOrphan Biovitrum AB (Sobi), with the product name Doptelet. In Europe and other regions, it is recognized and used by more and more medical institutions as an effective drug for the treatment of thrombocytopenia. Because original drugs have undergone rigorous clinical trials and regulatory review, they are generally considered to have a high degree of safety and effectiveness.

In addition to the original drug, there are also a variety of generic versions of avatrombopag on the market. The emergence of these generic drugs not only enriches patients' medication options, but may also be more cost-effective, thereby improving patient accessibility. Generic drugs are basically the same as the original drugs in terms of efficacy, specifications, indications and drug ingredients, which makes them effective substitutes for the original drugs.

In overseas markets, there are many generic drug manufacturers of avatrombopag, including Lao Daxiong Pharmaceutical, Lao Lucius Pharmaceutical, Lao United Pharmaceutical, as well as Bangladesh's Ziska Pharmaceutical and Yaopin International. By following international pharmaceutical production standards, these manufacturers ensure that the quality and efficacy of the generic drugs produced are similar to those of the original drugs. In addition, these manufacturers usually conduct strict compliance controls in local markets to ensure that their products can be used safely and effectively by patients.

Reference materials:https://www.doptelethcp.com/